ResMed ROE 2010-2023 | RMD

Current and historical return on equity (ROE) values for ResMed (RMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ResMed ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.89B $4.48B 21.22%
2023-09-30 $0.91B $4.25B 22.60%
2023-06-30 $0.90B $4.13B 23.58%
2023-03-31 $0.86B $3.93B 23.86%
2022-12-31 $0.81B $3.74B 23.43%
2022-09-30 $0.79B $3.43B 23.78%
2022-06-30 $0.78B $3.36B 24.35%
2022-03-31 $0.78B $3.28B 25.29%
2021-12-31 $0.52B $3.15B 17.78%
2021-09-30 $0.50B $3.03B 17.45%
2021-06-30 $0.48B $2.89B 17.06%
2021-03-31 $0.46B $2.71B 17.04%
2020-12-31 $0.70B $2.87B 27.15%
2020-09-30 $0.68B $2.68B 28.07%
2020-06-30 $0.62B $2.50B 27.26%
2020-03-31 $0.51B $2.26B 23.58%
2019-12-31 $0.46B $2.26B 21.49%
2019-09-30 $0.42B $2.12B 20.52%
2019-06-30 $0.41B $2.07B 20.38%
2019-03-31 $0.45B $2.02B 22.48%
2018-12-31 $0.45B $1.96B 22.60%
2018-09-30 $0.34B $1.90B 16.70%
2018-06-30 $0.32B $2.06B 15.42%
2018-03-31 $0.31B $2.07B 15.22%
2017-12-31 $0.29B $2.02B 14.51%
2017-09-30 $0.35B $2.05B 18.64%
2017-06-30 $0.34B $1.96B 18.80%
2017-03-31 $0.32B $1.86B 18.43%
2016-12-31 $0.33B $1.71B 19.09%
2016-09-30 $0.35B $1.77B 20.77%
2016-06-30 $0.35B $1.70B 22.23%
2016-03-31 $0.36B $1.67B 22.87%
2015-12-31 $0.36B $1.52B 23.38%
2015-09-30 $0.35B $1.46B 22.81%
2015-06-30 $0.35B $1.59B 22.12%
2015-03-31 $0.35B $1.54B 21.61%
2014-12-31 $0.35B $1.59B 21.05%
2014-09-30 $0.35B $1.65B 20.65%
2014-06-30 $0.35B $1.76B 20.41%
2014-03-31 $0.33B $1.69B 19.96%
2013-12-31 $0.33B $1.64B 19.43%
2013-09-30 $0.32B $1.69B 18.58%
2013-06-30 $0.31B $1.61B 17.98%
2013-03-31 $0.31B $1.77B 18.22%
2012-12-31 $0.29B $1.75B 17.46%
2012-09-30 $0.28B $1.70B 17.04%
2012-06-30 $0.26B $1.61B 16.18%
2012-03-31 $0.24B $1.61B 14.70%
2011-12-31 $0.23B $1.56B 13.84%
2011-09-30 $0.22B $1.55B 13.43%
2011-06-30 $0.23B $1.73B 13.95%
2011-03-31 $0.22B $1.66B 14.64%
2010-12-31 $0.22B $1.61B 15.21%
2010-09-30 $0.21B $1.48B 15.31%
2010-06-30 $0.19B $1.29B 14.96%
2010-03-31 $0.18B $1.33B 14.83%
2009-12-31 $0.17B $1.26B 15.13%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $27.032B $4.223B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.474B 24.35
Stryker (SYK) United States $128.161B 31.78
Boston Scientific (BSX) United States $106.966B 34.07
Medtronic (MDT) Ireland $106.730B 15.11
EssilorLuxottica (ESLOY) France $99.574B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.648B 0.00
Haleon (HLN) United Kingdom $38.127B 29.82
Terumo (TRUMY) Japan $25.476B 35.98
Zimmer Biomet Holdings (ZBH) United States $24.896B 16.03
Baxter (BAX) United States $20.785B 15.16
Koninklijke Philips (PHG) Netherlands $19.474B 15.53
Insulet (PODD) United States $11.711B 61.49
Smith & Nephew SNATS (SNN) United Kingdom $10.741B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.934B 23.64
BellRing Brands (BRBR) United States $7.285B 39.17
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.379B 22.40
Perrigo (PRGO) Ireland $4.232B 12.10
GN Store Nord (GNNDY) Denmark $3.937B 25.50
Envista Holdings (NVST) United States $3.485B 13.26
Prestige Consumer Healthcare (PBH) United States $3.482B 16.46
QuidelOrtho (QDEL) United States $2.730B 9.91
Neogen (NEOG) United States $2.679B 25.77
Green Thumb Industries (GTBIF) United States $2.630B 83.33
ICU Medical (ICUI) United States $2.357B 17.58
TG Therapeutics (TGTX) United States $2.161B 699.00
Maravai LifeSciences Holdings (MRVI) United States $1.928B 0.00
Owens & Minor (OMI) United States $1.895B 18.19
Verano Holdings (VRNOF) United States $1.790B 0.00
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
InMode (INMD) Israel $1.458B 7.55
LeMaitre Vascular (LMAT) United States $1.437B 47.43
National Vision Holdings (EYE) United States $1.388B 43.24
AdaptHealth (AHCO) United States $1.300B 9.78
Warby Parker (WRBY) United States $1.287B 0.00
AtriCure (ATRC) United States $1.115B 0.00
MacroGenics (MGNX) United States $0.982B 0.00
Canopy Growth (CGC) Canada $0.899B 0.00
BioLife Solutions (BLFS) United States $0.779B 0.00
Cresco Labs (CRLBF) United States $0.712B 0.00
VAREX IMAGING (VREX) United States $0.693B 14.98
Evolus (EOLS) United States $0.666B 0.00
Quanterix (QTRX) United States $0.613B 0.00
Jin Medical (ZJYL) China $0.547B 0.00
Valneva SE (VALN) France $0.540B 0.00
Phibro Animal Health (PAHC) United States $0.509B 11.02
PetIQ (PETQ) United States $0.487B 18.17
TerrAscend (TSNDF) Canada $0.478B 0.00
ZimVie (ZIMV) United States $0.430B 26.35
OraSure Technologies (OSUR) United States $0.421B 6.96
Biote (BTMD) United States $0.417B 3.96
Aurora Cannabis (ACB) Canada $0.393B 0.00
Surmodics (SRDX) United States $0.371B 40.11
Zynex (ZYXI) United States $0.361B 41.59
Viemed Healthcare (VMD) United States $0.314B 31.11
Cerus (CERS) United States $0.301B 0.00
Sanara MedTech (SMTI) United States $0.280B 0.00
TriSalus Life Sciences (TLSI) United States $0.274B 0.00
Utah Medical Products (UTMD) United States $0.241B 14.70
Organigram Holdings (OGI) Canada $0.199B 0.00
Veru (VERU) United States $0.193B 0.00
Ayr Wellness (AYRWF) United States $0.192B 0.00
Omeros (OMER) United States $0.176B 0.00
Quipt Home Medical (QIPT) United States $0.163B 0.00
High Tide (HITI) Canada $0.160B 0.00
Capricor Therapeutics (CAPR) United States $0.159B 0.00
Jushi Holdings (JUSHF) United States $0.134B 0.00
Eagleford Energy (GRUSF) United States $0.130B 65.20
FitLife Brands (FTLF) United States $0.129B 20.74
InterCure (INCR) Israel $0.122B 20.54
Fonar (FONR) United States $0.102B 8.80
Cellectar Biosciences (CLRB) United States $0.099B 0.00
MariMed (MRMD) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Allurion Technologies (ALUR) United States $0.088B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Zevia PBC (ZVIA) United States $0.060B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.059B 3.86
Apyx Medical (APYX) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.045B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 15.04
Bright Green (BGXX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Agape ATP (ATPC) $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 72.54
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00